Which begs the question. Why? How can the contractors possibly be this far behind when data lock was years ago, topline was about a year ago, and even MIA has been approved?
It’s probably Ken Griffith’s fault, or maybe Adam Feuerstein’s fault.
Which begs the question. Why? How can the contractors possibly be this far behind when data lock was years ago, topline was about a year ago, and even MIA has been approved?
Yes, hard to believe the MAA would not be complete 2-1/2 years after datalock.
novel dendritic cell vaccine. We are comparing it to things that aren't this complicated. This is a personalized approach for each patient based off of each individual tumor. I'd imagine it takes longer than we typically see for most drug approvals. I'm not freaking out on timelines. NWBO seems to methodically check off the boxes, albeit a bit slower than myself and maybe others want to see.